Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
European Journal of Medicinal Chemistry
|
April 2, 2014
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
Kunal Nepali, Sahil Sharma, Manmohan Sharma, et al.
Recent Patents on Anti-Cancer Drug Discovery
|
June 18, 2015
Purine Analogues as Kinase Inhibitors: A Review
Sahil Sharma, Samir Mehndiratta, Sunil Kumar, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
March 19, 2015
4,6-diaryl Pyrimidones as Constrained Chalcone Analogues: Design, Synthesis and Evaluation as Antiproliferative Agents
Dinesh Kumar, Kunal Nepali, P M S Bedi, et al.
Indian Journal of Dermatology, Venereology and Leprology
|
March 8, 2017
Malignant Melanoma of Oral Cavity
B R Garg, B M S Bedi, K N Tiwari, et al.
Clinical and Experimental Dermatology
|
June 5, 2003
Post-surgical zygomycotic necrotizing subcutaneous infection caused by Absidia corymbifera
G P Thami, S Kaur, A S Bawa, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 10, 2014
Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors
Harbinder Singh, Sahil Sharma, Ritu Ojha, et al.
Archiv Der Pharmazie
|
May 1, 2014
4,6-Diaryl/heteroarylpyrimidin-2(1H)-ones as a new class of xanthine oxidase inhibitors
Shiwani Shukla, Dinesh Kumar, Ritu Ojha, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology
|
June 17, 2009
CA 19-9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit?
M M S Bedi, M D Gandhi, G Jacob, et al.
Recent Patents on Anti-Cancer Drug Discovery
|
September 18, 2014
Anti-cancer pyrimidines in diverse scaffolds: a review of patent literature
Ramandeep Kaur, Prabhkirat Kaur, Sahil Sharma, et al.
European Journal of Medicinal Chemistry
|
February 25, 2016
Design strategies, structure activity relationship and mechanistic insights for purines as kinase inhibitors
Sahil Sharma, Jagjeet Singh, Ritu Ojha, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
European Journal of Medicinal Chemistry
|
April 2, 2014
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
Kunal Nepali, Sahil Sharma, Manmohan Sharma, et al.
Recent Patents on Anti-Cancer Drug Discovery
|
June 18, 2015
Purine Analogues as Kinase Inhibitors: A Review
Sahil Sharma, Samir Mehndiratta, Sunil Kumar, et al.
Anti-Cancer Agents in Medicinal Chemistry
|
March 19, 2015
4,6-diaryl Pyrimidones as Constrained Chalcone Analogues: Design, Synthesis and Evaluation as Antiproliferative Agents
Dinesh Kumar, Kunal Nepali, P M S Bedi, et al.
Indian Journal of Dermatology, Venereology and Leprology
|
March 8, 2017
Malignant Melanoma of Oral Cavity
B R Garg, B M S Bedi, K N Tiwari, et al.
Clinical and Experimental Dermatology
|
June 5, 2003
Post-surgical zygomycotic necrotizing subcutaneous infection caused by Absidia corymbifera
G P Thami, S Kaur, A S Bawa, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 10, 2014
Synthesis and evaluation of naphthoflavones as a new class of non purine xanthine oxidase inhibitors
Harbinder Singh, Sahil Sharma, Ritu Ojha, et al.
Archiv Der Pharmazie
|
May 1, 2014
4,6-Diaryl/heteroarylpyrimidin-2(1H)-ones as a new class of xanthine oxidase inhibitors
Shiwani Shukla, Dinesh Kumar, Ritu Ojha, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology
|
June 17, 2009
CA 19-9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit?
M M S Bedi, M D Gandhi, G Jacob, et al.
Recent Patents on Anti-Cancer Drug Discovery
|
September 18, 2014
Anti-cancer pyrimidines in diverse scaffolds: a review of patent literature
Ramandeep Kaur, Prabhkirat Kaur, Sahil Sharma, et al.
European Journal of Medicinal Chemistry
|
February 25, 2016
Design strategies, structure activity relationship and mechanistic insights for purines as kinase inhibitors
Sahil Sharma, Jagjeet Singh, Ritu Ojha, et al.
Page
of 3